Citation Information :
Prasad R, Shamim H, Rani H, Kacker R. Chronic Obstructive Pulmonary Disease (COPD) in Non-Smokers: A Different Phenotype?. Indian J Chest Dis Allied Sci 2021; 63 (3):203-206.
Chronic obstructive pulmonary disease (COPD) is a heterogeneous and multi-systemic disease with significantly increasing morbidity and mortality. COPD is now widely accepted to have multiple phenotypes. Tobacco smoking is very well recognised risk factor of COPD (25%–45% of patients with COPD have never smoked) and the burden of non-smoker COPD is increasing. This paper review in brief COPD in non-smokers, identification of various non-smoking risk factors that have contributed immensely in the causation of COPD and phenotypic variations which includes the existing and emerging phenotypes. It will also help us in proper diagnosis and pharmacological management of non-smoker COPD patients as their prevalence has been under-estimated.
Global Initiative for Chronic Obstructive Lung Disease (GOLD), Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2020 report. Available from URL: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19WMV.pdf. Accessed on June 20, 2021.
World Health Organization (WHO) Website. 2016. Available from URL: http://www.who.int. Accessed on June 20, 2021.
World Health Organization. Global Burden of Disease Website. 2016. Available from URL: http://www.who.int/topics/global_burden_of_disease. Accessed on June 20, 2021.
Padmavati S, Pathak SN. Chronic cor pulmonale in Delhi: a study of 127 cases. Circulation 1959;20:343–52.
Rana S. Incense sticks: a potential source of indoor air pollution. Int J Environ Engineer Management 2018;9:1–6.
Hagstad S, Bjerg A, Ekerljung L, Backman H, Lindberg A, Rönmark E, et al. Passive smoking exposure is associated with increased risk of COPD in never smokers. Chest 2014;145:1298–1304.
Dhar R, Biswas B, Kulkarni T, Limaye S, Ghoshal A. Tuberculosis associated obstructive lung disease: a pilot study. Eur Respir J 2018;52:PA4415; DOI: 10.1183/13993003.congress-2018.PA4415.
Prasad R, Verma SK, Mukherji PK, Jain N, Bhatia N, Ahuja RC. A cross sectional study of prevalence of deviated nasal septum (DNS) in patients with and without chronic bronchitis attending respiratory out patient's service. Indian J Otolaryngol Head Neck Surg 2005;2:466–8.
Miravitlles M, Calle M, Soler-Cataluña JJ. Clinical phenotypes of COPD. Identification, definition and implications for guidelines. Arch Bronconeumol 2012;48:86–98.
Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC). Prim Care Respir 2013;22:117–21.
Corlateanua A, Mendezb Y, Wangc Y, Garnicad RJA, Botnarua V, Siafakas N. Chronic obstructive pulmonary disease andphenotypes: a state-of-the-art. Pulmonology 2020;26:95–100.
Zhang J, Lin X, Bai C, Bai S. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study. Int J Chron Obstruct Pulmon Dis 2014;9:57–63
Krimmer D, Ichimaru Y, Burgess J, Black J, Oliver B. Exposure to biomass smoke extract enhances fibronectin release from fibroblasts. PLoS One 2013;8:e83938.
Bhome AB, Brashier B. Profiles of chronic obstructive lung disease: characteristics of stable chronic obstructive lung disease in different parts of Asia. Curr Opin Pulm Med 2014;20:165–72.
Fuller-Thomson E, Chisholm RS, Brennenstuhl S. COPD in a population-based sample of never-smokers: interactions among sex, gender, and race. Int J Chronic Dis 2016;586:20-26.
Denguezli M, Daldoul H, Harrabi I, Gnatiuc L, Coton S, Burney P, et al. COPD in nonsmokers: reports from the Tunisian population-based burden of obstructive lung disease study. PLoS One 2016;11:e0151981.
